Blesch KS - Search Results

1

Population pharmacokinetics and concentration-effect relationships of capecitabine metabolites in colorectal cancer patients.

Gieschke R, Burger HU, Reigner B, Blesch KS, Steimer JL. Gieschke R, et al. Among authors: blesch ks. Br J Clin Pharmacol. 2003 Mar;55(3):252-63. doi: 10.1046/j.1365-2125.2003.01765.x. Br J Clin Pharmacol. 2003. PMID: 12630975 Free PMC article. Clinical Trial.

2

Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience.

Blesch KS, Gieschke R, Tsukamoto Y, Reigner BG, Burger HU, Steimer JL. Blesch KS, et al. Invest New Drugs. 2003 May;21(2):195-223. doi: 10.1023/a:1023525513696. Invest New Drugs. 2003. PMID: 12889740 Review.

3

Population pharmacokinetic analysis of the major metabolites of capecitabine.

Gieschke R, Reigner B, Blesch KS, Steimer JL. Gieschke R, et al. Among authors: blesch ks. J Pharmacokinet Pharmacodyn. 2002 Feb;29(1):25-47. doi: 10.1023/a:1015716617967. J Pharmacokinet Pharmacodyn. 2002. PMID: 12194534

4

Estimating the starting dose for entry into humans: principles and practice.

Reigner BG, Blesch KS. Reigner BG, et al. Among authors: blesch ks. Eur J Clin Pharmacol. 2002 Feb;57(12):835-45. doi: 10.1007/s00228-001-0405-6. Eur J Clin Pharmacol. 2002. PMID: 11936701 Review.

5

Clinical pharmacokinetics of capecitabine.

Reigner B, Blesch K, Weidekamm E. Reigner B, et al. Clin Pharmacokinet. 2001;40(2):85-104. doi: 10.2165/00003088-200140020-00002. Clin Pharmacokinet. 2001. PMID: 11286326 Review.

6

A comparison of breast and colon cancer incidence rates among native Asian Indians, US immigrant Asian Indians, and whites.

Blesch KS, Davis F, Kamath SK. Blesch KS, et al. J Am Diet Assoc. 1999 Oct;99(10):1275-7. doi: 10.1016/S0002-8223(99)00313-2. J Am Diet Assoc. 1999. PMID: 10524396 No abstract available.

7

Rehabilitation of the cancer patient at home.

Blesch KS. Blesch KS. Semin Oncol Nurs. 1996 Aug;12(3):219-25. doi: 10.1016/s0749-2081(96)80039-8. Semin Oncol Nurs. 1996. PMID: 8857690 Review.

8

Applying the realized probability of dying to cancer survival.

Blesch KS, Freels S, Furner S, Davis F, Miles TP. Blesch KS, et al. J Clin Epidemiol. 1996 Aug;49(8):879-84. doi: 10.1016/0895-4356(96)00112-6. J Clin Epidemiol. 1996. PMID: 8699207

9

Health of older black Americans.

Blesch KS, Furner SE. Blesch KS, et al. Vital Health Stat 3. 1993 Jan;(27):229-73. Vital Health Stat 3. 1993. PMID: 8465260 Free article. No abstract available.

10

Life cycle issues affecting cancer rehabilitation.

O'Connor L, Blesch KS. O'Connor L, et al. Among authors: blesch ks. Semin Oncol Nurs. 1992 Aug;8(3):174-85. doi: 10.1016/0749-2081(92)90015-u. Semin Oncol Nurs. 1992. PMID: 1523365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters